Search Results 1111-1120 of 18340 for Hepatitis C

  1. Publications - Camille Francesca Hawkins, M.D. - Mayo Clinic

    ... C, Taylor G, Hawkins C, Persons P. A mixed ... C, Murphy R, Imade G, Okeke E, Akanmu A, Lesi O ... Gastro Hep Adv. 2025; 4 (6):100639 Epub 2025 Feb ...

  2. Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365) - Mayo Clinic

    ... C will receive pembrolizumab + enzalutamide. Outcome measures will be ... * Has known active Hepatitis B or Hepatitis C * Has received a live vaccine ...

  3. A Study of Niraparib Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy - Mayo Clinic

    Sponsor Protocol Number: PR-30-5017-C. About this study. This study is a ... Patient has known, active hepatic disease (i.e., hepatitis B or C). Patient ...

  4. PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer - Mayo Clinic

    Known infection with human immunodeficiency virus, Hepatitis B, or Hepatitis C; History of another primary cancer within the last 3 years with the exception ...

  5. C.difficile Archives - Mayo Clinic News Network

    've had recurring instances of C. diff. that normally is treated with antibiotics. I have read about fecal transplant as a potential treatment. How does this ...

  6. Ulcerative colitis - Symptoms and causes - Mayo Clinic

    Le Berre C, et al. Ulcerative colitis. The Lancet. 2023; doi:10.1016/S0140-6736(23)00966-2. Ulcerative colitis. National Institute of Diabetes and Digestive ...

  7. A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy - Mayo Clinic

    Positive hepatitis C virus (HCV) antibody at screening. Patients with positive hepatitis C antibody test result with no detectable HCV RNA for at least 12 ...

  8. Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007) - Mayo Clinic

    * Concurrent active Hepatitis B and Hepatitis C virus infection. * Human immunodeficiency virus (HIV)-infected participants with a history of Kaposi's ...

  9. A Study to Evaluate the Effectiveness and Safety of RalinEpag for Improving Treatment Outcomes in PAH Patients - Mayo Clinic

    ... C), portal hypertension, cirrhosis or complications of cirrhosis ... Confirmed active infection with hepatitis B virus (HBV) or hepatitis C virus (HCV).

  10. Mayo Clinic Sesquicentennial Title: Cancer, Choline C 11 and the Representative Date: February 2014 Intro

    use a new cancer marker, called C-11choline, to make those stealthy cancer cells light up. ... C-11 choline is a radioactive marker for cancer cells ...